Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b

Journal of Infectious Diseases

Volumn 198, Issue 1, 2008, Pages 125-133

  Hair, Pamela S ^a   Ward, Michael D ^a   Semmes, O John ^a   Foster, Timothy J ^d   Cunnion, Kenji M ^a,b,c,e  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Children's Specialty Group   (United States)

^c CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; CELL MEMBRANE PROTEIN; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR I; PROTEIN CLUMPING FACTOR A; RECOMBINANT PROTEIN;

ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; SERUM FACTOR; STAPHYLOCOCCUS AUREUS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; COAGULASE; COMPLEMENT C3B; COMPLEMENT FACTOR I; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS;

EID: 46349101373     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/588825     Document Type: Article

References (39)

1. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-85.
2. Chesney JP. Staphylococcus aureus. In: Long SS, Pickering LK, Prober CG, eds. Principals and practice of pediatric infectious diseases. New York: Churchill Livingstone, 2003: 694-707.
3. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32(Suppl 2):S114-32.
4. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987; 9:891-907.
5. Noskin GA, Rubin RJ, Schentag JJ, et al. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample database. Arch Intern Med 2005; 165:1756-61.
6. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436-44.
7. Goetz A, Posey K, Fleming J, et al. Methicillin-resistant Staphylococcus aureus in the community: a hospital-based study. Infect Control Hosp Epidemiol 1999; 20:689-91.
8. Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003; 111:1265-73.
9. Reis ES, Falcao DA, Isaac L. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol 2006; 63:155-68.
10. Takahashi K, Shi L, Gowda LD, Ezekowitz RA. Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection. Infect Immun 2005; 73:8188-93.
11. Cunnion KM, Lee JC, Frank MM. Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun 2001; 69:6796-803.
12. Gordon DL, Rice J, Finlay-Jones JJ, McDonald PJ, Hostetter MK. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization. J Infect Dis 1988; 157:697-704.
13. Cunnion KM, Zhang HM, Frank MM. Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis. Infect Immun 2003; 71:656-62.
14. Cunnion KM, Benjamin DK Jr, Hester CG, Frank MM. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia. J Lab Clin Med 2004; 143:358-65.
15. Cunnion KM, Hair PS, Buescher ES. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I. Infect Immun 2004; 72:2858-63.
16. Lambris JD, Sahu A, Wetsel RA. The chemistry and biology of C3, C4, and C5. In: Volanakis JE, Frank MM, eds. The human complement system in health and disease. New York: Marcel Dekker, 1998:83-118.
17. Ross GD, Polley MJ, Rabellino EM, Grey HM. Two different complement receptors on human lymphocytes: one specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med 1973; 138:798-811.
18. Cunnion KM, Buescher ES, Hair PS. Serum complement factor I decreases Staphylococcus aureus phagocytosis. J Lab Clin Med 2005; 146:279-86.
19. Kraiczy P, Wurzner R. Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol 2006; 43:31-44.
20. Horstmann RD, Sievertsen HJ, Knobloch J, Fischetti VA. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA 1988; 85:1657-61.
21. Janulczyk R, Iannelli F, Sjoholm AG, Pozzi G, Bjorck L. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J Biol Chem 2000; 275:37257-63.
22. Neeleman C, Geelen SP, Aerts PC, et al. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect Immun 1999; 67:4517-24.
23. Pandiripally V, Gregory E, Cue D. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1. Infect Immun 2002; 70:6206-14.
24. McCrea KW, Hartford O, Davis S, et al. The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. Microbiology 2000; 146:1535-46.
25. O'Connell DP, Nanavaty T, McDevitt D, Gurusiddappa S, Hook M, Foster TJ. The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site. J Biol Chem 1998; 273:6821-9.
26. O'Seaghdha M, van Schooten CJ, Kerrigan SW, et al. Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions. FEBS J 2006; 273:4831-41.
27. McDevitt D, Frančois P, Vaudaux P, Foster TJ. Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol 1995; 16:895-907.
28. McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 1994; 11:237-48.
29. Loughman A, Fitzgerald JR, Brennan MP, et al. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol 2005; 57:804-18.
30. Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ. Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Microbiol Lett 2006; 258:290-6.
31. Rosengard AM, Liu Y, Nie Z, Jimenez R. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc Natl Acad Sci USA 2002; 99:8808-13.
32. Liszewski MK, Leung MK, Hauhart R, et al. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J Immunol 2006; 176:3725-34.
33. Sahu A, Isaacs SN, Soulika AM, Lambris JD. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J Immunol 1998; 160:5596-604.
34. Mark L, Spiller OB, Villoutreix BO, Blom AM. Kaposi's sarcoma-associated herpes virus complement control protein: KCP - complement inhibition and more. Mol Immunol 2007; 44:11-22.
35. de Haas CJ, Veldkamp KE, Peschel A, et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004; 199:687-95.
36. Lee LY, Hook M, Haviland D, et al. Inhibition of complement activation by a secreted Staphylococcus aureus protein. J Infect Dis 2004; 190:571-9.
37. Lee LY, Liang X, Hook M, Brown EL. Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J Biol Chem 2004; 279:50710-6.
38. Rooijakkers SH, Ruyken M, Roos A, et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 2005; 6:920-7.
39. Rooijakkers SH, Ruyken M, van Roon J, van Kessel KP, van Strijp JA, van Wamel WJ. Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus. Cell Microbiol 2006; 8:1282-93.